Literature DB >> 34330476

Accomplishment of probiotics in human health pertaining to immunoregulation and disease control.

Kontham Kulangara Varsha1, Arun Padmakumar Maheshwari1, Kesavan Madhavan Nampoothiri2.   

Abstract

It is a well-established fact that the microbiome harboring the human body plays a critical role in maintaining human health and can influence treatments against various ailments. Human microbiome-based research contemplates the possibility of selecting and administering specific commensal bacterial strains to modulate the gut microbiota to attain favorable outcomes to the therapies. Consumption of probiotics and probiotic-based dietary supplements as functional foods has been a promising treatment strategy against various diseases. Clinical studies demonstrate that probiotic administration alters gut microbiota composition and instigates immune modulation in the host. The benefits of probiotics are reported to be strain-specific and depend on the host's baseline immune competence. This review explores the role of probiotics in alleviating symptoms of allergy, cancer, cardio vascular (CV) diseases, diabetes mellitus (DM), bowel diseases (IBD and IBS), periodontal disease, diseases affecting liver and kidney, neuroinflammatory diseases, and viral infections. Also, it surveyed the broad spectrum bioactive compounds produced by probiotics and possible mechanisms that trigger the immune system.
Copyright © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical; Diet; Immunomodulation; Microbiome; Probiotics; Therapy

Year:  2021        PMID: 34330476     DOI: 10.1016/j.clnesp.2021.06.020

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  3 in total

1.  Transcriptome analysis revealed growth phase-associated changes of a centenarian-originated probiotic Bifidobacterium animalis subsp. lactis A6.

Authors:  Hui Wang; Jieran An; Chengfei Fan; Zhengyuan Zhai; Hongxing Zhang; Yanling Hao
Journal:  BMC Microbiol       Date:  2022-02-25       Impact factor: 3.605

Review 2.  Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.

Authors:  Kayla Jaye; Dennis Chang; Chun Guang Li; Deep Jyoti Bhuyan
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

Review 3.  Update on gut microbiota in gastrointestinal diseases.

Authors:  Atsushi Nishida; Kyohei Nishino; Masashi Ohno; Keitaro Sakai; Yuji Owaki; Yoshika Noda; Hirotsugu Imaeda
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.